Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-,(3S,4R)-

CAS: 110429-36-2

Ref. IN-DA00IMIM

Informação sobre produto

• Nome: Piperidine,3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-,(3S,4R)-
• Sinónimos: [u'N-Methylparoxetine', u'110429-36-2', u'N-Methyl Paroxetine', u'Methylparoxetine', u'UNII-3X658583PO', u'3X658583PO', u'CPD000469181', u'(3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine', u'PubChem15206', u'MLS001424004', u'Paroxetine Related Compound F', u'(3S,4R)-N-Methylparoxetine', u'CHEMBL322363', u'CHEBI:94536', u'DTXSID20149243', u'MOJZPKOBKCXNKG-YJBOKZPZSA-N', u'HMS2051I12', u'BCP13507', u'ZINC2586028', u'CM0167', u'MFCD03788781', u'AKOS015851047', u'AKOS015889696', u'CCG-100867', u'NC00117', u'AC-18943', u'SAM001246633', u'SMR000469181', u"trans-(-)-4-(4'-FLUORO PHENYL)-3-[[3,4-(METHYLENEDIOXY)- PHENOXY]-METHYL]-N-METHYLPIPERIDINE", u'AB1004560', u'TC-063875', u'TL8000322', u'FT-0642703', u'M2645', u'429M362', u'C-20414', u'J-002423', u'BRD-K19277754-001-01-4', u'(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine', u'(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine', u'(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)-1-methylpiperidine', u"(3S,4R)-3-(3,4-Methylene-dioxyphenoxy-methyl)-4-(4'-fluorophenyl)-N-methylpiperidine", u'(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine', u'Paroxetine Related Compound F, United States Pharmacopeia (USP) Reference Standard', u'trans(-)-1-Methyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine', u'N-Methylparoxetine; (3S-trans)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-Piperidine; (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine', u'paroxetine', u'METHYL PAROXETINE', u'CID10947895', u'S-7965', u'Piperidina, 3-[(1,3-benzodioxol-5-iloxi)metil]-4-(4-fluorofenil)-1-metil-, (3s,4r)-'], (-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-1-methylpiperidine, (3S,4R)-3-(3,4-Methylene-dioxyphenoxy-methyl)-4-(4'-fluorophenyl)-N-methylpiperidine, (3S,4R)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine, 3-[(1,3-Benzodioxol-5-Yloxy)Methyl]-4-(4-Fluorophenyl)-1-Methylpiperidine, N-Methylparoxetine, PAR-Me, Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S,4R)-, Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methyl-, (3S-trans)-
• Marca: Indagoo

Propriedades químicas

• Peso molecular: 343.3920
• Fórmula: C₂₀H₂₂FNO₃
• Pureza: 98%
• Cor/forma: Solid
• InChI: InChI=1S/C20H22FNO3/c1-22-9-8-18(14-2-4-16(21)5-3-14)15(11-22)12-23-17-6-7-19-20(10-17)25-13-24-19/h2-7,10,15,18H,8-9,11-13H2,1H3/t15-,18-/m0/s1
• Chave InChI: MOJZPKOBKCXNKG-YJBOKZPZSA-N